Danaher appoints christopher riley to executive vice president for biotechnology

Washington , oct. 31, 2023 /prnewswire/ -- danaher corporation (nyse: dhr) ("danaher" or the "company"), a leading global life sciences and diagnostics innovator, today announced that christopher riley has been appointed by its board of directors to be executive vice president of danaher with responsibility for its biotechnology business, effective january 1, 2024. mr. riley, currently vice president and group executive of danaher's life sciences company with responsibility for genomic medicines, will become an executive officer of danaher reporting to president and chief executive officer, rainer blair.
DHR Ratings Summary
DHR Quant Ranking